Efficacy Of Octreotide In Initial Management Of Acute Variceal Bleed

Authors: Aftab Hussain Shah, Kouro Mal, Imdad Ansari, Ghulam Yasin, Azizullah Jalbani

CHANDKA MEDICAL COLLEGE (CMC) & HOSPITAL LARKANA, SINDH.
CMC & HOSPITAL LARKANA, SINDH.
CMC, LARKANA, SINDH.
CMC, LARKANA, SINDH.
CMC & HOSPITAL LARKANA, SINDH.

Volume 15 | Issue 3

Published: November 12, 2026

Abstract

Aim of study was to see the efficacy of octreotide alone as initial therapy
in controlling acute variceal bleeding. Design : It was randomized, prospective case control study. PLACE & Duration : Study was conducted in medical wards of Chandka Medical College Hospital from June 2003 to April 2004. Patients & Methods : Ninety patients who were fulfilling inclusion criteria and had esophageal varices as cause of bleeding confirmed on endoscopy were included in the study. Among them 63 (70%) were male and 27 (30%) were females. Their average age was 30 years. Upper GI endoscopy was performed within 24 hours after hemodynamic stabilization. Patients were randomly allocated in A & B Groups. All patients of Group A and 22 patients of Group-B revealed esophageal varices with active bleeding from varices in different grades (I, II, III) and cherry red spots. Grades of hepatic encephalopathy were made on admission and child-Pugh scoring were made after investigation. Group-A (61) patients received octreotide on admission and Group – B patients received placebo treatment (blood transfusions, intravenous fluids and proton pump inhibitors) on admission. But 22 patients of Group-B were given octreotide after endoscopy after 24 hours in whom cause of bleeding was esophageal varices. Octreotide was started in dose of 50-microgram IV bolus then infusion of 50 microgram per hour for 48 hour and then 50 microgram subcutaneously 8 hourly for 5 days. Results : Bleeding was controlled in 49 (80.3%) patients of Group-A within 12 hours of start of octreotide and 13 (59%) patients of Group-B bleeding was controlled after 24 hours P = 0.007. 10 (16.3%) patients of Group-A and 06 (20.6%) patients of Group-B showed rebleeding after 72 hours after initial control, this difference was statically significant P<O.Ol. The rebleeding was remarkable in Child-Pugh’s class B and C. 07 (11.4%) patients of Group-A and 08 (27.5%) patients of Group-B expired after 04 days of hospital stay. Conclusion : It was concluded that octreotide is an effective initial therapy to stop the acute variceal bleeding specially at places where definitive endoscopic procedures like sclerotherapy and esophageal variceal ligation are not available.

Keywords: Cirrhosis, portal hypertension, Esophageal varices, acute bleeding, octreotide.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF